News

UK report recommends medical trials of cannabis

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7169.1337a (Published 14 November 1998) Cite this as: BMJ 1998;317:1337
  1. Hugh Matthews
  1. BMJ

    Britain's House of Lords Science and Technology Committee recommended in a report published this week that cannabis should be reclassified as a schedule 2 drug, allowing research and prescription by doctors on a named patient basis.

    The report called for clinical trials of cannabis in the treatment of multiple sclerosis and chronic pain but recommended that doctors should …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe